Maria Gabriella Matera
Maria Gabriella Matera
No verified email
Cited by
Cited by
Pharmacology and therapeutics of bronchodilators
M Cazzola, CP Page, L Calzetta, MG Matera
Pharmacological reviews 64 (3), 450-504, 2012
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia
M Cazzola, F Imperatore, A Salzillo, F Di Perna, F Calderaro, ...
Chest 114 (2), 411-415, 1998
β2-agonist therapy in lung disease
M Cazzola, CP Page, P Rogliani, MG Matera
American journal of respiratory and critical care medicine 187 (7), 690-696, 2013
Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study
M Cazzola, MG Matera, G Santangelo, A Vinciguerra, F Rossi, G D'amato
Respiratory medicine 89 (5), 357-362, 1995
The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD
M Cazzola, F Di Marco, P Santus, B Boveri, M Verga, MG Matera, ...
Pulmonary pharmacology & therapeutics 17 (1), 35-39, 2004
β2‐adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta, MG Matera
British journal of pharmacology 163 (1), 4-17, 2011
Novel long‐acting bronchodilators for COPD and asthma
M Cazzola, MG Matera
British journal of pharmacology 155 (3), 291-299, 2008
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD
L Calzetta, P Rogliani, MG Matera, M Cazzola
Chest 149 (5), 1181-1196, 2016
Inhaled β2-Adrenoceptor Agonists
M Cazzola, MG Matera, CF Donner
Drugs 65 (12), 1595-1610, 2005
TNF-α inhibitors in asthma and COPD: we must not throw the baby out with the bath water
MG Matera, L Calzetta, M Cazzola
Pulmonary pharmacology & therapeutics 23 (2), 121-128, 2010
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
M Cazzola, L Calzetta, C Page, J Jardim, AG Chuchalin, P Rogliani, ...
European Respiratory Review 24 (137), 451-461, 2015
The functional impact of adding salmeterol and tiotropium in patients with stable COPD
M Cazzola, S Centanni, P Santus, M Verga, M Mondoni, F Di Marco, ...
Respiratory medicine 98 (12), 1214-1221, 2004
Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary disease
M Cazzola, MG Matera, J L÷tvall
Expert opinion on investigational drugs 14 (7), 775-783, 2005
Emerging inhaled bronchodilators: an update
M Cazzola, MG Matera
European Respiratory Journal 34 (3), 757-769, 2009
Relationship between zinc and obesity.
GM Di, MG Matera, BM De, C Vacca, SM Di, F Rossi
Journal of medicine 24 (2-3), 177-183, 1993
5-HT modifiers as a potential treatment of asthma
M Cazzola, MG Matera
Trends in pharmacological sciences 21 (1), 13-16, 2000
Clinical pharmacokinetics of salmeterol
M Cazzola, R Testi, MG Matera
Clinical pharmacokinetics 41 (1), 19-30, 2002
Novel bronchodilators for the treatment of chronic obstructive pulmonary disease
MG Matera, CP Page, M Cazzola
Trends in pharmacological sciences 32 (8), 495-506, 2011
Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease
M Cazzola, G Santangelo, A Piccolor, A Salzillo, MG Matera, G D'Amato, ...
Pulmonary pharmacology 7 (2), 103-107, 1994
Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study
M Cazzola, L Calzetta, G Bettoncelli, C Cricelli, F Romeo, MG Matera, ...
Respiratory medicine 106 (2), 249-256, 2012
The system can't perform the operation now. Try again later.
Articles 1–20